Slover Peter T 4
4 · SOPHIRIS BIO INC. · Filed Dec 8, 2017
Insider Transaction Report
Form 4
Slover Peter T
Chief Financial Officer
Transactions
- Award
Common Stock (Right to Buy)
2017-12-06+12,768→ 12,768 totalExercise: $1.91From: 2018-12-06Exp: 2027-12-05→ Common Stock (12,768 underlying)
Footnotes (1)
- [F1]33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on December 6, 2020.